Dasatinib, previously known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.
Product Description:
English name: Dasatinib
Other name: N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
CAS Number: 302962-49-8
Molecular Formula: C22H28ClN7O3S
Molecular Weight: 506.0208
InChI: 1/C22H26ClN7O2S.H2O/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31;/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27);1H2
Standard: USP/BP/CP/EP
Appearance: white crystalline powder
Specifications:
Spec.:Min 98% of Dasatinib
| Test Items | Specification | Results |
| Description | White to off white crystalline powder | Comply |
| Melting point | 166-170°C | 167.3-168.1°C |
| Identification | Positive reaction | Positive reaction |
| Related substances | ≤1.0% | 0.16% |
| Loss on drying | ≤0.5% | 0.06% |
| Residue on ignition | ≤0.1% | 0.02% |
| Chloride | ≤0.014% | <0.014 |
| Heavy Metals | ≤20ppm | <20ppm |
| Clarity of solution | Conform to standard | Complies |
| Microbial Limit | ≤20ppm | <20ppm |
| Assay | ≥99.0% | 99.12% |
Packaging & Shipping:
Package: By 25kgs/drum, inner by double plastic bag or as your request.
Storage Situation: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Shelf Life: Two years when properly stored.
Delivery: within two weeks after receiving your prepayment.
没有评论:
发表评论